3928146

Modifications on palindromic peptide LfcinB (21-25)Pal RWQWRWQWR to improve its colon cancer cytotoxic effect

Date
August 14, 2023
Explore related products in the following collection:

Anticancer peptides are considered alternatives in cancer treatment, due to their potency, selectivity, and low toxicity. The peptide LfcinB (21-25)Pal has previously shown in vitro anticancer effect against Caco-2 colon cancer cell line (IC50:86µM). In this work, we developed some modifications to the peptide sequence to increase its anticancer activity by means of N-terminal amino hexanoic (Ahx) inclusion, biotinylation, acetylation, and sequential Arg/Orn Changes. The molecules were synthesized by manual Solid Phase Peptide Synthesis (SPPS) and the synthetic feasibility (SAScore) ranged between 6.2 and 7.6, obtaining chromatographic purities higher than 90%. Finding better results on Ahx-RWQWRWQWR, and RWQWRWQW-Orn, as they presented activity against both cell lines Caco-2 and HT-29, and a decrease in the IC50 of about 50% in Caco-2 cells (IC50:40µM) when compared to the parent peptide. Equally, the hemolytic effect was lower for the modified peptides, showing values <10% when evaluated at 200µg/mL. For the best peptides, the toxicity was assessed under the Galleria Mellonella model, finding that the LD50 was >100 mg/Kg, which means its toxicity is classified as moderately toxic or lower. At this same concentration, cisplatin demonstrated a lethality of 90%. The designed anticancer peptides presented good in vitro activity and low toxicity, which makes them molecules of interest for future drug development studies.

Related Products

Thumbnail for Rational design of nitrogen-doped carbon dots for inhibiting b-amyloid aggregation
Rational design of nitrogen-doped carbon dots for inhibiting b-amyloid aggregation
Abstract: The fibrillization and abnormal aggregation of b-amyloid (Ab) peptides are commonly
Thumbnail for Development of chitosan-functionalized with and ACE2 receptor derived peptide to neutralize SARS-CoV virus
Development of chitosan-functionalized with and ACE2 receptor derived peptide to neutralize SARS-CoV virus
SARS-CoV-2 are spherical enveloped virions (50-200 nm in diameter), containing positivel y sense single-stranded RNA. Its virus genome encodes for four structural proteins, among them the SPIKE protein assembles into homotrimers, and forms structures that protrude from the vi rion envelope…
Thumbnail for Chemical synthesis of hydrazineacetic acid for inhibitory activity against bacteria
Chemical synthesis of hydrazineacetic acid for inhibitory activity against bacteria
This paper presents a novel synthetic study of methylhydrazineacetic acid from the acyclic homoallylamine as an intermediate…
Thumbnail for Studies of delayed release of anti-leukemia drug 6-thioguanine: Aluminum metal-organic frameworks as drug encapsulation matrices
Studies of delayed release of anti-leukemia drug 6-thioguanine: Aluminum metal-organic frameworks as drug encapsulation matrices
For advanced chemotherapeutics with nanomaterials, it is important to develop strategies for controlled time-delayed drug release, using specially designed encapsulation matrices. 6-thioguanine (6-TG) is a major antimetabolite drug for treating acute myeloid leukemia and Crohn's disease…